Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial
Kentaro Machida,1,* Tomotaka Kawayama,2,* Masaharu Kinoshita,3,* Masakazu Ichinose,4 Tohru Tsuda,5 Shohei Takata,6 Hiroshi Koto,7 Makoto Yoshida,8 Yoshinori Ashihara,9 Masaru Kawashima,10 Hideaki Suna,10 Hiromasa Inoue1 1Department of Pulmonary Medicine, Graduate School of Medical and Dental Science...
Main Authors: | Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/imidafenacin-an-orally-active-muscarinic-receptor-antagonist-improves--peer-reviewed-article-COPD |
Similar Items
-
Characterization of muscarinic receptor binding by the novel radioligand, [3H]imidafenacin, in the bladder and other tissues of rats
by: Shiori Kuraoka, et al.
Published: (2016-07-01) -
Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy
by: Tong Cai, et al.
Published: (2020-12-01) -
Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors
by: Li Liu, et al.
Published: (2021-09-01) -
Evaluation of gut modulatory and bronchodilator activities of <it>Amaranthus spinosus</it> Linn.
by: Chaudhary Mueen, et al.
Published: (2012-10-01) -
Muscarinic Receptor Binding of the Novel Radioligand, [3H]Imidafenacin in the Human Bladder and Parotid Gland
by: Akira Yoshida, et al.
Published: (2014-01-01)